No Data
Bitcoin, Ethereum, Dogecoin Mirror Stocks, Rise Amid $120,000 BTC Prediction In Q2: ETH Needs Daily Close Above $1,950 For Bullish Bias, Says Analyst
A JPMorgan survey indicates that the S&P 500 Index has peaked this year, but investors remain bullish on the Magnificent 7.
① A JPMorgan survey shows that 93% of investors believe the S&P 500 Index will hover around 6000 points or lower in the next 12 months, with 40% expecting it to remain within the 5000-5500 points Range; ② Respondents unanimously believe that trade wars and tariff uncertainties will trigger economic consequences, with 61% expecting the USA economy to face stagflation in the next 12 months.
Goldman Sachs: Oral weight loss drugs will be one of the most promising new medications in recent years!
Goldman Sachs predicts that by 2030, oral weight loss drugs will account for 24% of the total weight loss drug market, and Eli Lilly and Co will lead this segment with its orforglipron. Next, pay close attention to the third-quarter results of the ATTAIN-1 trial announced by Eli Lilly, which will be the first reading of orforglipron in the field of obesity and the most important next catalyst for the oral obesity drug market.
Exxon Poised to Overtake European Rivals Including Shell, BP on Low Carbon Spending - FT
Alexandria Ocasio-Cortez Asks,'How Much Did Majorie Taylor Greene Make When She Bought The Dip?'
$100 Invested In This Stock 10 Years Ago Would Be Worth This Much Today
